e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The pathophysiological role of novel pulmonary arterial hypertension gene
SOX17
Yukyee Wu, John Wharton, Rachel Walters, Eleni Vasilaki, Jurjan Aman, Lan Zhao, Martin R. Wilkins, Christopher J. Rhodes
Source:
Eur Respir J, 58 (3) 2004172; 10.1183/13993003.04172-2020
Journal Issue:
September
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Yukyee Wu, John Wharton, Rachel Walters, Eleni Vasilaki, Jurjan Aman, Lan Zhao, Martin R. Wilkins, Christopher J. Rhodes. The pathophysiological role of novel pulmonary arterial hypertension gene
SOX17
. Eur Respir J, 58 (3) 2004172; 10.1183/13993003.04172-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Asbestosis
Whole genome sequencing of the highly virulent subtype B0/W148 of the Beijing genotype M.tuberculosis in Kharkiv, East Ukraine
Related content which might interest you:
CFTR involvement in the pathogenesis of pulmonary arterial hypertension
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020
Towards an understanding of pulmonary arterial hypertension (PAH): gene regulation patterns in pulmonary arterial resistance vessels of patients with PAH
Source: Eur Respir J 2006; 28: Suppl. 50, 526s
Year: 2006
Interleukin-13-dependent regulation of endothelin-1 expression in pulmonary arterial hypertension
Source: Annual Congress 2007 - Pulmonary hypertension
Year: 2007
Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (5) 2000653; 10.1183/13993003.00653-2020
Year: 2021
Endothelial NO and its pathophysiologic regulation
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007
A novel piperidine attenuates pulmonary arterial hypertension via regulating BMP2 and PTGS2 levels
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
Survivin inhibition as a potential target for pulmonary arterial hypertension
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019
Expression of fetal genes in pulmonary arterial hypertension
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005
The emerging role of epigenetics in pulmonary hypertension
Source: Eur Respir J 2016; 48: 903-917
Year: 2016
Novel insights into the pathogenesis of pulmonary arterial hypertension
Source: Virtual Congress 2020 – Pulmonary vascular diseases
Year: 2020
Targeting HIF2a-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension
Source: Eur Respir J, 57 (3) 1902061; 10.1183/13993003.02061-2019
Year: 2021
The dual role of apoptosis in pulmonary hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005
Gene expression alterations in mice lacking the VIP gene are conducive to pulmonary arterial hypertension and pulmonary vascular remodeling
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
A novel piperidine identified by stem cell-based screening attenuates pulmonary arterial hypertension by regulating BMP2 and PTGS2 levels
Source: Eur Respir J, 51 (4) 1702229; 10.1183/13993003.02229-2017
Year: 2018
Hypoxia-induced miR-130a is a novel repressor of BMPR2 gene expression in experimental pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms
Year: 2012
Circulating microRNA signature and its novel involvement in pathogenesis of chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
A novel murine model of severe pulmonary arterial hypertension
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010
The role of fractalkine in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept